Walleye Capital LLC Ani Pharmaceuticals Inc Transaction History

Walleye Capital LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$58.53 - $68.82 $634,991 - $746,628	10,849 New	10,849 $690,000
Q3 2023 Nov 14, 2023	BUY	$50.28 - $64.61 $426,826 - $548,474	8,489 New	8,489 $492,000
Q3 2020 Nov 16, 2020	SELL	$26.38 - $33.1 $243,619 - $305,678	-9,235 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$29.93 - $50.1 $276,403 - $462,673	9,235 New	9,235 $299,000
Q1 2020 May 15, 2020	SELL	$30.35 - $67.14 $7,253 - $16,046	-239 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$55.65 - $79.83 $593,395 - $851,227	-10,663 Reduced 97.81%	239 $15,000
Q3 2019 Nov 14, 2019	BUY	$64.7 - $85.39 $468,816 - $618,735	7,246 Added 198.19%	10,902 $794,000
Q2 2019 Aug 14, 2019	BUY	$67.77 - $82.2 $205,749 - $249,559	3,036 Added 489.68%	3,656 $301,000
Q1 2019 May 15, 2019	BUY	$45.83 - $70.54 $28,414 - $43,734	620 New	620 $44,000

212

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $973M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.